Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/06/bfly-stock-whipsaws-as-midjourney-scanner-deal-takes-center-stage.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

BFLY Stock Whipsaws As Midjourney Scanner Deal Takes Center Stage

TIM BOHENUPDATED JUN. 23, 2026, 2:03 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

Butterfly Network Inc. gains as stocks have been trading up by 7.7 percent following upbeat sentiment on its imaging technology.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading BFLY

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

  • Midjourney Medical launched a full-body tomographic ultrasound scanner embedding Butterfly Network’s Ultrasound-on-Chip modules under a co-development and licensing deal that may deliver up to $74M over five years.
  • The new Midjourney scanner uses 40 Butterfly Ultrasound-on-Chip modules per system, with future generations expected to use even more, signaling rising hardware and licensing volume.
  • Management will appear at TD Cowen’s Medical Devices Emerging Growth Call Series on 2026/06/18 to update traders on Butterfly Network’s technology and licensing roadmap.
  • Shares of BFLY dropped 18.8% to $7.22 in a single session, reflecting sharp selling pressure despite bullish partnership headlines.
  • A Form 4 filing revealed a change in beneficial ownership of Butterfly Network securities by an insider or major holder, a signal traders often track for sentiment clues.

Candlestick Chart

Live Update At 14:02:47 EDT: On Tuesday, June 23, 2026 Butterfly Network Inc. stock [NYSE: BFLY] is trending up by 7.7%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Butterfly Network, trading under ticker BFLY, has been on a wild ride. In late May the stock chopped around the mid-$4s. By 2026/06/03 it was still near $4.39, not exactly a momentum darling. Then the picture changed fast.

From early June, BFLY pushed from roughly $4.5 to $8.9 by 2026/06/18, almost a double in about two weeks. That kind of move screams momentum trading and short covering. After the spike, the stock pulled back hard, including a brutal 18.8% slide to $7.22, before bouncing to $7.84 on 2026/06/23. The daily chart now shows a steep, V-shaped run-up followed by high-volatility consolidation.

More Breaking News

Intraday on 2026/06/23, BFLY held a tight range between roughly $7.5 and $7.9 for hours, showing strong liquidity and active day trading. Fundamentally, Butterfly Network booked about $97.6M in revenue over the last year with a healthy 49.2% gross margin, but operating margins are deeply negative and cash burn is real. Q1 2026 free cash flow was about -$14.8M, although the balance sheet carried roughly $142M of cash and minimal debt. For traders, BFLY is a classic high-risk, high-reward story: strong tech and plenty of cash, but still far from profitability.

Why Traders Are Watching BFLY Right Now

BFLY is back on radar because the story around its Ultrasound-on-Chip platform just got a major real-world test. Midjourney Medical publicly launched a full-body tomographic ultrasound scanner that embeds Butterfly Network’s modules under an existing co-development and licensing deal. Management says this arrangement could deliver up to $74M over five years, and that number can scale if the platform gains traction.

For a company with sub-$100M annual revenue, a $74M opportunity over a multi-year window is not background noise. It is meaningful. Even more important, Butterfly Network confirmed each Midjourney scanner uses 40 BFLY Ultrasound-on-Chip modules. Future generations are expected to use substantially more. That is where traders should focus: every scanner shipped drags multiple BFLY modules along with it. If Midjourney ramps volumes, BFLY enjoys leverage on both licensing and hardware pull-through.

At the same time, Butterfly Network has been highlighted as a key name in handheld ultrasound and point-of-care imaging, leaning on hardware plus AI to democratize access. That narrative supports longer-term multiple expansion, but the tape tells a more conflicted story. Despite bullish headlines, BFLY shares recently fell 18.8% in a single session to $7.22, a clear sign that some traders are selling strength or doubting execution.

Adding another wrinkle, a Form 4 filing disclosed a change in beneficial ownership by an insider or major holder. We do not have direction from this data alone, but filings around big moves often attract attention. With management set to speak at TD Cowen’s Emerging Growth Call Series on 2026/06/18, short-term traders will be watching closely for any fresh color on the Midjourney deal, module volumes, and licensing strategy that might move BFLY again.

Conclusion

BFLY sits at the crossroads of big promise and real risk. On one side, Butterfly Network’s Ultrasound-on-Chip technology is finally scaling into a serious commercial platform via Midjourney’s full-body scanner. A deal that may bring up to $74M over five years, with systems already using 40 BFLY modules and the potential for higher counts later, gives traders a clear revenue path to model. On the other side, the income statement is still bleeding. Q1 2026 showed about $26.5M in revenue but more than $13.8M in operating losses and roughly -$14.8M in free cash flow. Cash of about $142M buys time, not a free pass.

The recent 18.8% single-day drop to $7.22, followed by a bounce into the high-$7s, tells you exactly what BFLY is right now: a volatility engine tied to news, filings, and expectations. The Form 4 insider-ownership change only adds to that sense of a battleground tape.

For active traders, the setup is straightforward but not easy. Track how the Midjourney ramp actually translates into numbers, listen closely to Butterfly Network’s messaging at TD Cowen, and respect every big gap on the chart. As Tim Sykes likes to remind his students, “Patterns repeat, but only traders who cut losses quickly, stay disciplined, and never believe the hype survive long enough to take advantage of them.” In the same vein, learning to avoid chasing and to accept when a move has already happened is critical; as Tim Bohen, lead trainer with StocksToTrade says, “Time and experience have taught me that missed opportunities are part of the game. There’s always another setup around the corner.” BFLY is a live case study in that mindset. This analysis is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders